Use of health data by the life sciences industry: a UK perspective

Improving lives by enabling discoveries through health data

Medicines Discovery Catapult

This report explores the use of health data and the barriers faced by the UK life sciences industry. It highlights the tangible steps being taken by UK stakeholders to deliver a ‘clear, credible national offer’ for the R&D community, which would be in the public interest. It also highlights areas where further joint effort is needed for the UK to be globally competitive.

The report was released in collaboration with the Association of the British Pharmaceutical Industry (ABPI).

Six key industry requirements for health data emerged from the research:

  • Data breadth, depth, and scale
  • Access and speed
  • High-quality data
  • Expertise
  • Public trust
  • Affordability

Read the report

Want a brief overview of the findings? Download the Key Insights report >